Search for: "EISAI, INC."
Results 81 - 92
of 92
Sort by Relevance
|
Sort by Date
22 Jul 2008, 4:54 am
In Eisai Co. v. [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
30 Mar 2008, 8:26 pm
USA, No. 05-5727 (D.N.J. 2008) Eisai Co., Ltd., the Japanese manufacturer of Aricept (donepezil hydrochloride), has won a preliminary injunction against Teva Pharmaceuticals USA, Inc., keeping Teva's generic version of Aricept off the market for the time being. [read post]
28 Dec 2007, 1:00 am
Rodriguez (Patry Copyright Blog),KSR and the doctrine of equivalents: (The Fire of Genius),PLI poll results - 68% say eliminate rule 56: (PLI),Design patents - controlling pendency: (Patently O),USPTO to halt weekly paper publication of USPTO Practice and Procedure Notices: (Patent Docs) AT&T - Vonage to settle with AT&T in patent infringement dispute: (Ars Technica),eBay - US District Court finds eBay intentionally… [read post]
18 Dec 2007, 9:05 pm
Eisai's presence in the U.S. [read post]
13 Dec 2007, 8:26 pm
By Suresh Pillai -- Last month, Morphotek, Inc., a subsidiary of Eisai Co., Ltd. based in Exton, Pennsylvania, announced that it had been granted U.S. [read post]
12 Dec 2007, 4:55 pm
By Jason Derry -- Eisai Co., Ltd. and MGI PHARMA, Inc. have announced that Eisai will acquire MGI PHARMA for approximately $3.9 billion. [read post]
18 Nov 2007, 5:57 pm
Eisai Co., Ltd. et al. v. [read post]
18 May 2007, 1:23 am
Washington Mutual Inc. [read post]
12 May 2007, 8:31 pm
Reddy's Laboratories Ltd. of India was also involved in the case.]Johnson & Johnson Inc. co-markets Aciphex with Eisai reported $1.24 billion in 2006 sales of the acid reflux drug worldwide. [read post]
31 Oct 2006, 6:12 am
(Headquarters: Tokyo, President and CEO: Haruo Naito) and Eisai Inc. [read post]
16 Oct 2006, 7:58 pm
Source: Eisai press release. [read post]
